Daniel Bickley to Recombinant Fusion Proteins
This is a "connection" page, showing publications Daniel Bickley has written about Recombinant Fusion Proteins.
Connection Strength
0.068
-
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease. Blood. 2008 Feb 15; 111(4):2470-5.
Score: 0.068
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.